Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04586075 · ClinicalTrials.gov registry record

UW Undiagnosed Genetic Diseases Program

A clinical trial of Genetic Disease and Rare Diseases, sponsored by University of Wisconsin, Madison.

Recruiting
Registry status
500
Enrollment target
1
Study location

NCT04586075 is a study of Genetic Disease and Rare Diseases that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 500 participants, below the 2,545-participant average among 30 other Genetic Disease trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04586075, a study of Genetic Disease and Rare Diseases, is actively recruiting participants, sponsored by University of Wisconsin, Madison.

RECRUITING
Registry status
500 participants
Enrollment target
1
Study location

Study Summary

The primary purpose of this study is to discover new disease genes for rare Mendelian disorders and its secondary purpose include diagnosing people with rare genetic disorders that have not been previously diagnosed through conventional clinical means, learning more about the pathobiology of genetic disorders, and developing novel diagnostic technologies and analytics. 500 participants with undiagnosed and suspected genetic disorders will be recruited.

Interventions

  • DIAGNOSTIC_TEST Trio Whole Genome Sequencing and Participant-Specific Research

Study Locations (1)

Wisconsin

  • University of Wisconsin School of Medicine and Public Health - Madison

Trial Details

FieldValue
Enrollment Target 500 participants
Start Date 2021-07-16
Est. Completion 2030-10

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT04586075

The ClinicalTrials.gov registry entry for NCT04586075 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,545-participant average among 30 other Genetic Disease trials with a reported enrollment target (80% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Genetic Disease appearing as the primary indexed condition, and to 1 intervention - of which Trio Whole Genome Sequencing and Participant-Specific Research is the first listed.

NCT04586075 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT04586075 about?

NCT04586075 is a clinical study titled "UW Undiagnosed Genetic Diseases Program". The primary purpose of this study is to discover new disease genes for rare Mendelian disorders and its secondary purpose include diagnosing people with rare genetic disorders that have not been previously diagnosed through conventional clinical means, learning more about the pathobiology of genetic...

What is the current status of trial NCT04586075?

This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2021-07-16. Estimated completion is 2030-10.

What conditions does trial NCT04586075 study?

This clinical trial studies the following conditions: Genetic Disease, Rare Diseases, Undiagnosed Disease.

What interventions are being tested in trial NCT04586075?

The interventions under investigation include: Trio Whole Genome Sequencing and Participant-Specific Research (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04586075?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04586075 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Genetic Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.